01 - SUBCUTANEOUS TANEZUMAB FOR OSTEOARTHRITIS: A 24-WEEK PHASE 3 STUDY WITH A 24-WEEK FOLLOW UP

Francisco Blanco

Ali Guermazi

Kenji Miki

Takaharu Yamabe

Lars Viktrup

Rod Junor

William Carey

Mark T Brown

Christine R West

Ken Verburg

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com